Research programme: small molecule therapeutics - Evotec AG/Fraunhofer IME

Drug Profile

Research programme: small molecule therapeutics - Evotec AG/Fraunhofer IME

Latest Information Update: 18 Oct 2014

Price : $50

At a glance

  • Originator Evotec AG; Fraunhofer Institute for Molecular Biology and Applied Ecology
  • Class Small molecules
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Research Unspecified

Most Recent Events

  • 08 Jul 2014 Early research in Undefined indication in Germany (unspecified route)
  • 08 Jul 2014 Evotec AG and Fraunhofer Institute for Molecular Biology and Applied Ecology enters into collaboration for the development of small molecule therapeutics
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top